Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Major histocompatibility complex class II genes and systemic sclerosis.

D Briggs1, K I Welsh

  • 1Molecular Immunogenetics, Guy's Hospital, London.

Annals of the Rheumatic Diseases
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation.

International journal of immunogenetics·2021
Same author

The possibility of determining the age of colonies of clonally propagating herbaceous species from historic records: the case of Aster novi-belgii L. (first recorded as A. salignus Willd.) at Wicken Fen Nature Reserve, Cambridgeshire, England.

The New phytologist·2017
Same author

The effect of source of supplemental dietary calcium and magnesium in the peripartum period, and level of dietary magnesium postpartum, on mineral status, performance, and energy metabolites in multiparous Holstein cows.

Journal of dairy science·2017
Same author

ABO-incompatible renal transplantation without antibody removal using conventional immunosuppression alone.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Meeting report: 3rd international transplant conference: how much risk can you take?

International journal of immunogenetics·2015

Genetic markers show promise for diagnosing and predicting systemic sclerosis (SSc) subtypes and treatment responses. Further research into MHC and collagen gene interactions is needed for breakthroughs.

Area of Science:

  • Immunogenetics
  • Rheumatology
  • Molecular Biology

Background:

  • Systemic sclerosis (SSc) associations with the Major Histocompatibility Complex (MHC) are not strong enough for direct clinical use across all ethnic groups.
  • MHC associations are valuable for classifying SSc into limited cutaneous and diffuse cutaneous subtypes.
  • Emerging evidence links specific genetic markers to autoantibody production in SSc, similar to findings in systemic lupus erythematosus.

Purpose of the Study:

  • To explore the diagnostic and prognostic significance of genetic markers in specific systemic sclerosis patient subsets.
  • To investigate the relationship between genetic markers, autoantibody production, and collagen overproduction in SSc.
  • To understand the mechanistic role of MHC in SSc pathogenesis and its potential for guiding treatment strategies.

Related Experiment Videos

Main Methods:

  • Analysis of Major Histocompatibility Complex (MHC) associations with systemic sclerosis (SSc) and its subtypes.
  • Examination of genetic markers in relation to autoantibody production and clinical phenotypes, such as lung fibrosis.
  • Comparative analysis of MHC associations in other autoimmune diseases (e.g., lupus, diabetes, rheumatoid arthritis) to inform SSc research.

Main Results:

  • MHC associations support SSc classification but lack overall clinical utility for diagnosis.
  • Specific genetic markers are increasingly important for diagnosing and predicting prognosis in SSc subsets, like those with lung fibrosis.
  • Genetic markers can link chemically induced scleroderma-like disorders to classical SSc, exemplified by vinyl chloride disease.

Conclusions:

  • Genetic tests may eventually guide SSc treatment for certain patients, pending a deeper understanding of genetics and collagen overproduction.
  • The association of autoantibodies with topoisomerase I offers a potential link between MHC and collagen gene expression.
  • Precise subtyping of MHC class II genes and haplotype characterization are crucial for fully understanding MHC's contribution to SSc.